In the present study, we focus on the correlation between DUSP6 expression and clinicopathological features, the mechanisms by which DUSP6 affects the ESCC cells and the possible epigenetic mechanisms involved in the abrogation of DUSP6 in ESCC cells. This evidence concerns the gene DUSP6 and esophageal squamous cell carcinoma.